{"transactions":[{"id":1297961,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":83998,"kind":"person","name":"Rasbach Kyle","position":1,"cik":"0002050086","reported_name":"Rasbach Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-22T16:55:05.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":245250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on December 18, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":245250,"derivative":{"exercise_price":5.07,"expiration_date":"2035-01-16","underlying":"Common Stock","underlying_shares":245250},"source":{"system":"sec-edgar","filing":"0001415889-25-001859","document":"form4-01222025_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2050086/000141588925001859/form4-01222025_040101.xml","form_type":"4"}},{"id":1297960,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":83998,"kind":"person","name":"Rasbach Kyle","position":1,"cik":"0002050086","reported_name":"Rasbach Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-22T16:55:05.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":40875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported securities are RSUs."}],"balance_after":40875,"source":{"system":"sec-edgar","filing":"0001415889-25-001859","document":"form4-01222025_040101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050086/000141588925001859/form4-01222025_040101.xml","form_type":"4"}}]}